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INTRODUCTION
Differentiation of cells from multipotent and pluripotent progenitors is essential for 
the development of multicellular organisms. In turn, there is great therapeutical potential 
in  manipulation  and  control  of  such  differentiation  processes  for  cancer.  The 
hematopoietic system is one of the best-studied systems of the differentiation process 
and has established that all cell types within the mammalian lymphoid system originate 
from a common progenitor found in the bone marrow. Understanding the genetic and 
molecular mechanisms that control the development of lymphocytes from this progenitor 
is important for therapeutics of cancers originating in lymphocytes such as B and T cell  
lymphomas. A detailed understanding of lymphoid cell development would further our 
understanding of the molecular basis for these pathologic conditions. Lymphopoiesis is  
a well-understood differentiation process mainly because there are well defined existing 
methods for in vitro differentiation in culture. Lymphopoiesis studies have not only led to 
a  deeper  understanding  of  lymphoid  cell  development,  but  have  also  provided  key 
insight into malignant processes in which genes responsible for the differentiation of 
lymphocytes  were  targets  in  cellular  transformation.  As  the  sole  source  of 
immunoglobulin, B lymphocytes (or B cells) are an essential component of the adaptive 
immune system. 
B cell development
B  cells,  like  all  hematopoietic  cells,  are  produced  from  self-renewing 
hematopoietic stem cell within the fetal liver and postnatal bone marrow. Throughout 
life, the self renewing, pluripotent hematopoietic stem cells (HSCs) regenerates all blood 
cell types in a stepwise process by differentiating into a progenitor cell with a gradual  
restricted developmental potential ().
An early step of hematopiesis in bone marrow is the generation of multipotent 
progenitors  (MPPs)  through  HSCs.  MPPs  give  rise  to  either  a  lymphoid-primed 
multipotent progenitors (LMPPs) or common myleoid progenitors (CMPs), which in turn 
can differentiate into an erythroid and a myeloid cell. LMPPs seed the thymus and the 
bone  marrow  where  they  differentiate  into  lymphocytes.  The  differentiation  process 
transits through the common lymphoid progenitor (CLP) stage. CLP is currently viewed 
as a bone marrow intermediate, primarily progenitor of B lymphocytes and NK cells but  
can give rise to  dendritic  cells  (DC) and has residual  T  lineage potential,  but  lacks 
myeloid potential. Cells than proceed through early B cell development that includes the 
pre-pro-B cell, pro-B cell, pre-B cell, immature B cell, mature B cell, and plasma cell  
stages.  These  stages  are  defined  by  progression  of  immunoglobulin  gene  DNA 
recombination,  expression  of  cell  surface markers,  and expression  of  transcriptional 
regulators.
Production and Immunological Characterization of Justy Mice 
Our laboratory has been characterizing a novel mutant mouse strain called Justy, 
which  was  created  via  random,  genome-wide  mutagenesis  at  Ingenium 
Pharmaceuticals. Male C3HeB/FeJ (C3H) mice were injected with ENU and mated with 
wild-type  C3H females.  An  F1  male,  excluded from carrying  a  potentially  dominant 
mutation, was mated with wild-type C3H females producing G2 offsprings. G2 females 
were crossed with the F1 male to produce G3 offspring. Flow cytometric analysis of 
peripheral blood from F3 progeny identified mice lacking cells expressing CD45R/B220 
(B220), a marker found almost exclusively on B cells [19]. G3 founder was crossed to 
wild-type C3H mice and the progeny used for brother-sister matings to recover mice that 
were homozygous for the causal mutation [65]. The mutant strain was named Justy (just 
T cells). Serum immunoglobulin was not detected in these mice and injection of LPS or  
Ficoll failed to induce IgM synthesis as observed in control mice. Spleens from  Justy 
mice  are  abnormally  small  in  size  and  weight;  histologically,  this  correlates  with 
hypoplasia  and  reduced  cell  numbers  in  white  pulp  regions.  Total  B  cells  in  Justy 
splenocytes are decreased ~500-fold relative to wild type. B cells are undetectable in 
Justy lymph node cells and the frequency of B1 and B2 cells in Justy peritoneal exudate 
cells is greatly reduced. 
Reciprocal bone marrow transplantation demonstrated that  Justy bone marrow 
stroma  can  support  B  cell  development  from  wild-type  progenitors  and  the 
developmental defect caused by the Justy mutation is intrinsic to B cell progenitors. 
The mutation is associated with the Gon4l gene
Simple sequence length polymorphisms (SSLPs) analysis showed a complete 
association between the developmental block and a region on mouse chromosome 3 
(chr 3) between SSLPs D3Mit49 and D3Mit175. Sequence analysis of the candidate 
region revealed a T to A transversion at nucleotide position 88703382 in chr 3 within 
intron 24 of the mouse gene Gon4l (gon4-like), Mutagenesis of C. elegans identified the 
prototypical Gon4l ortholog, named gon-4. Characterization of four mutant alleles, each 
probably being null,  demonstrated that gon-4 is required solely for cell  divisions that  
generate somatic gonadal organs. Each of two independent mutagenesis screens of 
zebrafish  identified  a  recessive  loss-of-function  allele  for  the  Gon4l ortholog  Udu. 
Homozygosity for either allele results in abnormal gastrulation, cell death in the central 
nervous system and disruption of early erythropoiesis. Although Gon4l  orthologs have 
been identified in vertebrate genomes as well, we know very little about its function.
AIMS OF THE STUDY
The main goals of the present study were:
1. To analyze the genetic locus associated with the observed phenotype.
2. To analyze Gon4l gene product at mRNA and protein level.
3. To identify target genes regulated by Gon4l.
4. Analysis of earlier precursors during B cell development.
5. To define the in vitro differentiation potential of bone marrow cells from Justy 
mice.
6. Analysis of the mouse Gon4l paralog gene.
7. To analyze the role of Socs7 in TSLP and IL-7 signaling
METHODS
Mice 
Justy mice were generated at Ingenium (Germany) by introducing point mutations 
in the male  C3HeB/FeJ (C3H)  germline via injection N-ethyl-N-Nitrosourea. Mutations 
were screened by positional cloning. Socs7 KO mice were created as described before. 
For experiments, 129/Bl6 mixed KO mice as well as wild-type 129/Bl6 F2 hybrid mice 
were used.
Flow Cytometric Analysis and Cell Sorting
Single cell suspensions were prepared from spleen, thymus or bone marrow by 
removing red blood cells and debris using lympholyte or by lysing red blood cells with 
ACK buffer followed by passage through a 70μM cell strainer. Cells were resuspended 
in  stain  buffer  (PBS  containing  3%  FBS)  and  incubated  with  anti-mouse  CD16/32 
(eBioscience)  to  prevent  nonspecific  antibody  binding.  Cells  were  incubated  with 
fluorochrome- or  biotin-conjugated antibodies for  30 min on ice and then washed 3 
times with stain buffer. Optimal antibody concentrations for staining were determined by 
titration experiments. To label biotin-conjugated antibodies, cells were resuspended in 
stain  buffer  plus  the  appropriate  concentration  of  streptavidin-  or  avidin-conjugated 
fluorophore, incubated for additional 30 min on ice and then washed 3 times with stain 
buffer. Flow cytometric analysis was performed using either an LSR II or a FACSDiVa 
(Becton Dickinson). Collected data was analyzed with FlowJo software (TreeStar). Cell  
yields for different fractions were calculated from post-sort analysis of collected data. 
Total  events in the appropriate gate were divided by the total  events in the forward 
scatter versus side scatter gate; this percentage was then multiplied by total yield of 
splenocytes  or  bone  marrow  cells  as  determined  by  counting  viable  cells  using  a 
hemacytometer. Cell populations were sorted using a FACSDiVa. For isolation of pre-
pro-B and pro-B cells from bone marrow, a negative selection step was performed prior 
to sorting. Cells were incubated with rat monoclonal antibodies (Ter-119, anti-CD5, anti-
Ly6C and anti IgM), washed and then incubated with magnetic beads coated with sheep 
anti-rat antibodies (Dynal). Beads and unwanted cells were selected out and cells in the 
supernatant  were  recovered,  stained  with  antibodies  and  then  sorted.  For  sort-
purification, antibodies specific for the following cell-surface markers were used: B220, 
CD43, CD11c, CD49b, CD19, HSA and BP-1. For sort-purification 8-12 week-old mice 
were used, 6-8 mice per sort. 
RNA Purification 
Mouse organs were quick frozen in liquid N2 and homogenized in 1ml of TriZol 
(Invitrogen) per 50mg of tissue using a PowerGen Homogenizer (Fisher). Homogenetes 
were centrifuged for 10 min at 14000 rpm and supernatants were incubated for 5 min at 
room temperature (RT). Samples were shaken for 15 sec after the addition of 200μl of 
chloroform per 1ml of starting TriZol and incubated for 2-3 minutes at room temperature. 
After centrifugation for 20 min at 14000 rpm at 4oC the aqueous phase was transferred 
to a new tube and 500μl of isopropanol  was added per 1ml of  starting TriZol. After 
incubation for  10  min at  room temperature samples were  centrifuged for  10 min at 
10000rpm at 4oC. Pellets were dried and resuspended in nuclease free water. Samples 
were treated with DnaseI (Roche) and cleaned up using RNeasy mini columns (Qiagen) 
following the manufacturer’s instruction. 
Sort purified cells were homogenized in 800µl of TriZol by vortexing. After, the 
same procedure was used as described above. Pellet was resuspended in 21.5  µl of 
nuclease free water and was treated with 1 µl of DNase I (Invitrogen) in the presence of 
10µl of 10x DNase buffer for 15 min at room temperature. The reaction was stopped by 
adding  2.5µl  of  25mM  EDTA  (pH  8.0).  25µl  out  of  this  mix  was  used  for  reverse 
transcription.
Primers and RT-PCR Analysis
Isolated RNA was reverse-transcribed using the SuperScript III First-strand cDNA 
Synthesis  Kit  (Invitrogen).  Conventional  PCR  was  performed  using  Taq  enzyme 
(Qiagen)  and  BioRad  MyCycler  thermal  cycler  according  to  the  manufacturers’ 
instructions.  Quantitative real-time PCR was performed using POWER SYBR Green 
Master Mix and the ABI PRISM 7700 Detection system (Applied Biosystems) to obtain 
cycle  threshold (Ct)  values for  target  and internal  reference cDNA levels.  Ct values 
correspond to the PCR cycle at which fluorescent signals above baseline fluorescence 
are detected; baseline was determined using fluorescence readings collected during the 
first  12-15 cycles  of  PCR amplification.  Target  cDNA levels  were  normalized  to  an 
internal reference using the equation 2-[ΔCt], where ΔCt is defined as Ct  target – Ct  internal 
reference. Values shown were derived from the average of 3 or more replicate pairs of PCR 
reactions (target  and internal  reference) for each of 2 to 6 independently generated 
cDNA preparations. 
To present data in Section 3, values were first normalized to HPRT as described 
above. After, expression values shown for wt early pro-B,  Justy pre-pro B and  Justy 
early proB cells were all normalized to the value obtained from wild-type pre-pro B cells, 
which was set to 1.
Cloning
Overlapping DNA fragments spanning the entire Gon4l coding sequence were 
obtained by PCR amplification of cDNA from wild-type bone marrow. Fragments were 
cloned  into  pCR2.1  (Invitrogen)  and  sequenced.  Standard  methods  were  used  to 
assemble  a  full  length  Gon4l  cDNA from that  was fused in  frame at  the  5’  end to 
sequences encoding the HA epitope. HA-Gon4l cDNA was inserted into the retroviral 
vector pMIG immediately upstream of an IRES and GFP coding sequences, allowing for  
co-expression of HA-Gon4l and GFP from a bicistronic mRNA. HA-Gon4l cDNA was 
also inserted into  the mammalian expression plasmid pcDNA 3.1 HisB- (Invitrogen). 
Effectene (Qiagen) was used to transiently transfect human embryonic kidney (HEK) 
293T cells with pMIG-HA-Gon4l. 
Indirect Immunofluorescent Confocal Microscopy
After  transfection,  cells  were  trypsinized  and  transferred  to  glass  coverslips 
coated with poly-L-lysine (Sigma). 48 hr after transfection, cells were washed and fixed 
with 4% paraformaldehyde for 30 min at RT. After fixation, cells were washed 4 times for 
10 minutes, permeabilized and blocked by incubation in PBS containing 2% FBS and 
0.1%  Triton  X-100  for  30  min  at  RT.  Cells  were  incubated  overnight  with  anti-HA 
antibody (clone 3F10, Roche) diluted 1 to 500 in Stain buffer (PBS containing 2% FBS 
and 0.05% Tween 20). Bound anti-HA antibody was detected using biotinylated goat 
anti-rat  IgG (Jackson ImmunoResearch) diluted 1 to 200 in Stain buffer followed by 
Alexa  Fluor  568-streptavidin  (Molecular  Probes)  diluted  in  Stain  buffer.  Cells  were 
incubated with each reagent for 30 min at RT and then washed 4 times for 10 min. Cells 
were then incubated for 5 min at RT with TOPRO3 (Invitrogen) diluted 1 to 2000 in Stain  
buffer and rinsed. Vectashield (Vector Laboratories) was used to mount cover slips onto 
microscopy slides.  Data images were collected using a Radience 2100MP Confocal 
Microscope (Bio-Rad). 
Identification of Putative Protein Domains
Putative  protein  structural  domains  were  identified  using  the  SMART 
(http://smart.emblheidelberg.de/smart/set_mode.cgi?NORMAL=1)  and  Pfam 
(http://www.sanger.ac.uk/Software/Pfam/) databases.
Cell culture
Each cell types were grown in a 37°C humidified, 5% CO2 gassed incubator.
S17 culture -  S17 stromal cells were grown in 10% FBS/RPMI 1640 medium 
(supplemented  with  1  x  glutamine,  10  mM  Hepes,  50uM  β-ME,  and  1%  PS).  For 
maintaining  the  cell  line,  cells  were  passaged  before  reaching  confluence.  For 
experiments, cells were passaged into 24-well plates in the same medium and allowed 
to reach confluence before use. 
OP9 culture - OP9-control and OP9-DL1 cell lines were obtained from Dr. Juan 
Carlos Zúñiga-Pflücker (University of Toronto, Canada). OP9-control cells and OP9-DL1 
cells were cultured as a monolayer in OP9 media (MEM supplemented with 20% FCS, 
1% penicillin and streptomycin and 2.2 g/liter sodium bicarbonate).  For experiments,  
cells were passaged into 24-well  plates in the same medium and were used before 
reaching confluence. 
Whitlock-Witte culture - 2 x 106/ml total bone marrow of 8-12 week-old wild-type 
and  Justy mice was plated onto confluent layer of S17 stromal cell  layer in medium 
(RPMI-1640, 5% heat inactivated FCS, 50µM β-mercaptoethanol (β-ME) and 1% PS) in 
the  presence  of  12.5  ng/ml  IL-7.  After  10-14  days,  cells  in  the  supernatant  were 
analyzed by flow cytometry using B220, CD19, CD43, Gr-1, Ly6c and CD49b.
B/myeoid cell inducing condition - Wild-type and Justy pre-pro-B and early pro-B 
cells were sort-purified from bone marrow of 8-12 week-old mice and 2x103 cells were 
plated directly into wells on a 24 well plate containing a confluent monolayer of S17 
stromal cells. All cells were grown in α-MEM medium supplemented with 5% FBS, 50µM 
β-ME and 1% PS in the presence of IL-7, SCF and Flt3L (each at 10 ng/ml). After 7-14  
days, cells were harvested by pipetting, and then stained with antibody to CD19, Ly6c,  
Gr-1 and CD11b and analyzed by flow cytometry. 
T cell inducing condition -  Pre-pro-B and early pro-B cells from 8-12 week-old 
wild-type and Justy mice were sort-purified and 2x103 cells were plated into wells on a 
24-well plate containing a sub-confluent layer of either OP9-GFP or OP9-DL1 cells. All 
cells  were  grown  in  α-MEM  medium  supplemented  with  20%  FBS,  2.2g/l  sodium 
bicarbonate and 1% PS in the presence of  IL-7 and Flt3L (each at  10 ng/ml),  IL-6  
(ng/ml) and IL-15 (25ng/ml) to enhance the growth of B, T and NK cells. After 7-10 days, 
wells were scored for growth. Cells from individual wells were harvested and stained for 
expression of B220, CD19, CD90/Thy-1, CD25 and CD49b. CD90+CD25+ cells were 
considered as early T cells. 
Mast  cell  culture  -  Mouse  bone  marrow  derived  mast  cells  (BMMCs)  were 
cultured from marrow cells of the femur and tibia of 129/ Bl6 Socs7+/- or Socs7−/−  mice. 
These cells were maintained in RPMI 1640 medium supplemented with 10% FBS, 100 
U/ml  penicillin,  100  μg/ml  streptomycin,  25  mM HEPES,  1.0  mM sodium pyruvate, 
nonessential amino acids (BioSource International, Camarillo, CA), 0.0035% β-ME and 
300 ng/ml recombinant mouse IL-3 (PeproTech, Rocky Hill, NJ) as described. BMMCs 
(>95% purity  as  determined by  toluidine  blue  staining)  were  used at  4–6 weeks of 
culture. For sensitization,  BMMCs were seeded at 2×105 cells/well and sensitized for 
with 100 ng/ml IgE anti-DNP (Sigma-Aldrich) for 30 min, 2h and 4h.
Western analysis and immunoprecipitation
Cellular lysates were homogenized in NP-40 lysis buffer containing 0.5% NP-40, 
50 mM Tris pH 8.0, 10% glycerol, 0.1 mM EDTA, 150 mM NaCl, 0.5 mM Na3VO4, 4.5 
mM Na2P4O7,  50  mM NaF,  1  mM DTT,  0.4  mM PMSF,  3  μg/ml  aprotinin,  1  μg/ml 
leupeptin, and 2 μg/ml pepstatin. The homogenates were solubilized for 1 hour at 4°C 
and clarified by centrifugation at 16,000 g for 30 minutes. Supernatants containing equal 
amounts of protein (2–3 mg) were immunoprecipitated (≥ 2 hours or overnight) with 2 μg 
of α-X-press (Invitrogen Corp.) or α-HA (Roche) antibodies. Immune complexes were 
collected with 60 μl of a 50% slurry of protein A agarose (Santa Cruz) resolved on 12% 
SDS–PAGE and transferred to nitrocellulose. The blots were probed with antibodies 
against X-press epitope (Invitrogen Corp.) or HA epitope (Roche).
Statistical analyses
All the statistical analyses were performed using GraphPad Prism version 5.00 
for Windows (GraphPad Software, Sand Diego, CA, USA). P values below 0.5 were 
considered significant. 
RESULTS AND DISCUSSION
The Justy mutation disrupts RNA splicing 
Sequence analysis identified a T to A transversion roughly in the center of an 876 
nucleotide intron between exons 24 and 25 of the predicted  Gon4l  gene. The T to A 
transversion increases homology to the consensus 5’ splice site, suggesting that the 
mutation could affect pre-mRNA splicing. Primers complementary to exons 24 and 26 in 
Gon4l were used to amplify cDNA derived from different organs by PCR. Amplification 
of cDNA generated from wild-type organs gave rise to a 446 bp product that consisted 
of the expected sequences. However, amplification of cDNA derived from Justy organs 
generated a 446 bp product as well as a prominent 527 bp product and a minor 638 bp 
product. Sequence analysis showed that the 446 bp product is identical to that amplified 
from wild-type cDNA. In contrast, in addition to the expected sequences, the 527 bp and 
638 bp products contained cryptic exons between exons 24 and 25: an 81 nt cryptic  
exon in the case of the 527 bp fragment and a 192 bp cryptic exon in the case of the 
638 bp product. The 192 nt cryptic exon consists of the 81 nt exon fused at the 5’ end to 
an  additional  111  nt.  The  sequence  common  to  both  cryptic  exons  is  located 
immediately upstream of the T to A mutation in the  Justy genome. Inclusion of either 
cryptic exon into Gon4l mRNA requires the use of sequences surrounding the T to A 
mutation as a 5’ splice site in concert with the 3’ splice site that defines the beginning of 
exon 25. The T to A mutation also activates the use of splice sites that mediate fusion of  
the cryptic exons to the end of exon 24. Strikingly, inclusion of either the 81 nt or 192 nt  
cryptic exon places termination codons in frame with the coding sequence of Gon4l 
mRNA;  thus  mRNA  containing  either  the  81  nt  or  192  nt  cryptic  exon  encodes  a 
truncated  form of  Gon4l  lacking  the  last  626  C-terminal  amino  acids  of  the  native 
protein.
Gon4l mRNA is broadly expressed in various tissues
Q RT-PCR analysis was used to define how the  Justy  mutation affects Gon4l 
RNA expression.  With the exception of brain, total  Gon4l RNA levels were modestly 
reduced in organs from Justy mice relative to those from wild type. The wild-type splice 
was detected in cDNA generated from wild-type or  Justy organs. The aberrant splice 
was undetectable  in  cDNA derived from wild-type organs but  was abundant  in  that 
generated from  Justy organs, indicating that the effect of the mutation is widespread. 
Moreover, the levels of the wild-type and aberrant splice detected in cDNA from Justy 
organs were inversely related. For example, in  Justy brain, low levels of the aberrant 
splice and normal levels of the wild-type splice were observed, while in  Justy thymus, 
spleen or bone marrow, high levels of the aberrant splice and low levels of the wild-type 
splice were seen. These results suggest that tissue and cell-specific factors influence 
the  effect  of  the  Justy mutation  at  the  level  of  pre-RNA splicing.  Furthermore,  the 
mutation has a profound effect on the splicing of Gon4l RNA in pre-pro-B and early pro-
B cells, which correlates well with the nature of the developmental block. 
Gon4l mRNA is expressed in B cell  progenitors and upregulated during B cell  
maturation 
Quantitative (Q) RT-PCR analysis was performed to measure the levels of Gon4l 
RNA expressed in wild-type cells at various stages of B lymphopoiesis. Consistent with 
the phenotype of Justy mice, Gon4l RNA was detected in pre-pro-B and early and late 
pro-B cells. Relative to pre-pro-B cells, Gon4l RNA levels were somewhat lower in pro-B 
cell fractions as well as in pre-B cells. In contrast, Gon4l RNA levels in immature B cells, 
bone marrow fraction F and splenic follicular and marginal zone (MZ) B cells were equal 
to or greater than that detected in pre-pro-B cells, suggesting that Gon4l expression is  
upregulated with B cell maturation. 
Justy mutation abolishes synthesis of wild-type Gon4l mRNA in pre-pro-B and 
early pro-B cells
As  Gon4l  mRNA  is  expressed  during  B  lymphopoiesis,  we  asked  how  the 
mutation affects Gon4l mRNA levels in wild-type and Justy pre-pro-B and early pro-B 
cells. Similar levels of total Gon4l RNA were detected in Justy and wild type pre-pro-B 
and early pro-B cells. The aberrant splice was undetectable in cDNA derived from wild-
type pre-pro-B and early pro-B cells, as expected, but was clearly present in Justy cells. 
The inverse  relationship  was  observed for  the  wild-type splice:  this  was present  at 
robust levels in wild-type pre-pro-B and early pro-B cells but was nearly undetectable in 
Justy  cells.  These results indicate that the  Justy mutation abolishes synthesis of wild-
type  Gon4l mRNA in  pre-pro-B  and  early  pro-B  cells,  which  is  consistent  with  the 
observed developmental block. 
The observation that Gon4l is widely expressed seems to argue against the idea 
that Gon4l expression is important only in the B lineage. A more likely explanation for 
how  the  Justy  mutation  specifically  disrupts  B  lymphopoiesis  comes  from our  data 
demonstrating that the mutation has a profound effect on Gon4l  pre-mRNA splicing. 
These observations suggest the Justy mutation has created a conditional allele of Gon4l 
rather than one with complete and constitutive loss of function. 
Gon4l encodes a putative regulator of chromatin
The Gon4l gene contains 33 exons with a predicted open reading frame spanning 
exons 2-33. The encoded protein is 2260 amino acids with a predicted molecular weight 
of ~250 kDa. Computer analysis identified several regions in Gon4l with homology to 
other proteins that regulate transcription and chromatin. The N-terminal of the Gon4l 
protein contains a predicted nuclear localization signal (NLS), suggesting that Gon4l is a 
nuclear protein. 293T cells were transiently cotransfected with a plasmid expressing HA-
epitope-tagged Gon4l; immunoblot confirmed that Gon4l was expressed. Fluorescent 
confocal  microscopy  demonstrated  that  Gon4l  accumulated  mainly  in  the  nucleus, 
although in some cells it was also found in the cytoplasm, but was excluded from the  
nucleolus. In contrast, a Gon4l derivative lacking 318 amino acids spanning the putative 
NLS near the N-terminus failed to localize to the nucleus. These results demonstrate 
that  Gon4l  encodes  a  nuclear  protein.  The  predicted  structural  domains  and  the 
demonstration  that  Gon4l  localizes  in  the  nucleus  suggest  that  Gon4l  functions  to 
regulate gene transcription.
Regulation of gene expression is disrupted in Justy B cell progenitors
As Gon4l  protein  is  predicted  to  form domains  associated  with  regulation  of 
transcription, we evaluated gene expression in sort-purified pre-pro-B and early pro-B 
cells via Q RT-PCR analysis. We observed a significant decrease in IL7Rα expression 
in  Justy early pro-B cells, which might result in decreased survival and expansion of 
these cells.  Early pre-pro-B cells from  Justy mice expressed significantly more PU.1 
RNA compared to their wild-type counterpart. This may be important in the light of the in  
vitro  experiments  where  increased  PU.1  expression  was  shown  to  suppress  B  cell 
development. We also measured levels of RNA encoding key B cell transcription factors 
including E2A (E12 and E47) and Ebf1, which are absolutely required for pre-pro-B to  
early pro-B transition. RNA levels in Justy cells were not considerably different relative 
to that detected in wild-type cells. In case of Pax5 RNA, there is a modest increase in 
both pre-pro-B and early pro-B cells relative to wild type. These data suggest that the 
changes in E2A, EBF or Pax5 expression are not responsible for the Justy phenotype 
and that mechanisms required for regulation of lymphoid and B cell-associated genes 
during B lineage commitment are largely intact in Justy cells. 
Analysis  of  RNA  encoding  components  of  the  immunoglobulin  gene 
rearrangement machinery (RAG1 & 2, TdT) showed slight decrease of RAG1 and RAG2 
expression in both pre-pro-B and early pro-B cells relative to wild type, however, the 
differences were not significant. On the other hand, there was a significant decrease in 
the expression of the TdT RNA in Justy cells. Tdt is a key player in influencing the 
outcome of V(D)J recombination during lymphocyte development. 
We have also observed significant differences in the expression of some genes 
important for the formation of the pre-BCR complex. Both VpreB1 and  λ5, which are 
important for the formation of surrogate light chain of the preBCR, were downregulated 
in Justy early pro-B cells relative to wild type cells. Igα forms heterodimer with Igβ and 
are  together  responsible  for  signal  transduction  of  the  preBCR.  Levels  of  Igβ 
significantly increased in Justy early pro-B cells compared to wild type. 
We also tested whether RNA expression from alternative lineage genes (i.e. T 
cell or myeloid-associated genes) was altered in sort-purified pre-pro-B and early pro-B 
cells.  During  development  of  pre-pro-B  cells  into  early  pro-B  cells,  T  and  myeloid-
associated genes are repressed. Levels of RNA encoding the T lineage factors Notch1 
or GATA3 were increased in Justy pre-pro-B cells, although the difference did not reach 
significance. On the other hand, Notch1 RNA level was significantly increased in early  
pro-B cells relative to wild type. This result is interesting as Notch signaling has been  
suggested to have a role in determining lineage choice in developing T cells and can 
suppress B cell development. 
Levels of RNA encoding the myeloid factors C/EBPα or Csf1r were also elevated 
in  Justy pre-pro-B cells  compared to  wild  type.  Strikingly,  in  Justy early  pro-B cells 
C/EBPα and  Csf1r  RNA  levels  were  increased  17-fold  and  77-fold,  respectively, 
compared to wild-type cells. Csf1r and Cebpα are myeloid specific genes and their RNA 
expression are normally low or absent in B cell progenitors.  Our data indicate that the 
mechanisms required for repression of at least some alternative (non-B) lineage genes 
is disrupted in  Justy cells. Repression of alternative lineage genes coincides with the 
pre-pro-B  cell  transition,  resulting  in  complete  commitment  to  the  B  cell  fate  and 
restriction of alternative lineage potential. Thus, our data suggest that the inability to 
completely  repress  alternative  lineage  genes  is  in  part  responsible  for  the 
developmental block observed in Justy mice. 
Normal CLPs but increased numbers of CMPs present in Justy bone marrow cells
Although the block in  Justy mice occurs during the transition from pre-pro-B to 
pro-B cells we sought to  determine whether Gon4l  has a role earlier  during lineage 
commitment and might affect the development of other lineages. During hemopoiesis, 
multipotent progenitors differentiate into common myeloid progenitors (CMPs) that give 
rise to erythrocytes and myeloid cells, and the common lymphoid progenitors (CLPs) 
that are the immediate precursors of pre-pro-B cells. The frequency and total number of 
CLPs in Justy bone marrow was normal. These data indicate that CLPs are not grossly 
affected by the  Justy mutation. On the other hand, CMPs showed a clear increase in 
Justy bone marrow compared to wild type. Although the difference was not significant, 
we observed this difference each time when analyzing bone marrow population, even in 
samples from old (10 month-old) mice. 
Block in B cell development is caused by the Justy mutation
In order to better understand the mechanism underlying the developmental block 
caused by the Justy mutation, we tested the potential of bone marrow cells to develop 
into B cells using Witlock-Witte in vitro culture. We co-cultured total Justy bone marrow 
with  S17  stromal  cells  and  IL-7.  Wild-type  cultures  proliferated  and  expansion  was 
clearly visible by eyes under the microscope, while in Justy culture, very few cells could 
be collected from the supernatant. FACS analysis of the cells collected from wild type 
culture  revealed  that  the  majority  of  the  cells  are  B220+CD19+ B  cells,  while  Justy 
cultures failed to generate cells expressing these markers. These results indicate that 
exogenous stromal cells and IL-7 cannot  overcome the block in B cell  development 
caused by the Justy mutation. 
The number of cells that develop into non-B cells are very similar in wild type and Justy 
cultures,  suggesting  that  cells  in  the  Justy culture  do  not  have  higher  tendency  to 
develop  into  B220+CD19- and  B220-CD19- cells.  However,  we  cannot  rule  out  the 
possibility that in a certain cytokine milieu they take on an alternative fate as a result of  
their retained developmental plasticity. 
Alternative lineage potential of purified Justy pre-pro-B and early pro-B cells: fail 
to differentiate in B/myeloid inducing cultures
We tested the alternative lineage potential of sort-purified  Justy pre-pro-B and 
early pro-B cells. Stromal cell co-culture experiments have provided important insights  
regarding  the  stages  at  which  developmental  potential  is  restricted  during  B  cell  
development.  We  hypothesize  that  Gon4l functions  to  establish  a  gene  expression 
pattern  that  is  necessary  for  the  pre-pro-B  to  early  pro-B  cell  transition.  More 
specifically, our preliminary gene expression analysis suggests that Gon4l is required to 
fully repress transcription from non-B lineage genes. A prediction stemming from this 
hypothesis is that loss of Gon4l function will increase the developmental plasticity of pre-
pro-B cells due to their inability to shut down alternative lineage genes. 
Wild-type and  Justy pre-pro-B  cells  were  sort-purified  and populations  plated 
directly into wells on a 24 well plate containing a confluent monolayer of S17 stromal  
cells and in the presence of IL-7, SCF and Flt3 ligand. After 7-14 days, wells were 
scored for growth. Wild type pre-pro-B and early pro-B cells expanded well, while Justy 
cultures had very few cells present in the culture. Wild-type pre-pro-B and early pro-B 
cells produced almost exclusively B220+CD19+ B cells. In Justy cultures, pre-pro-B cells 
were able to produce some B220+CD19+ B cells although their number was very low. 
Instead, these cells proliferated into Ly6c+ myeloid cells, which corresponds with the fact 
that pre-pro-B cells retain some residual myeloid potential. However, early pro-B cells 
from the  Justy culture hardly produced any B or myeloid cells. These results suggest 
that, although Justy pre-pro-B cells are capable of producing some B220+CD19+ B cells 
in vitro, they do not expand even in the presence of IL-7, suggesting that there is a block 
downstream of the IL-7 signaling pathway.
Justy pre-pro-B cells differentiate under T/NK cell inducing condition
To  further  test  the  developmental  potential  of  Justy cells,  we  performed  a 
preliminary experiment where pre-pro-B and early pro-B cells from wild-type and Justy 
mice were sort-purified and populations plated into wells on a 24-well plate containing a 
confluent layer of either OP9-GFP or OP9-DL1 cells. After 7-10 days, wells were scored 
for growth. The OP9-GFP culture provides a negative control system where no Notch 
signal is present, thus the cells are unable to differentiate into T/NK cells. In the OP9-
DL1 system, where the Notch-1 ligand (DL1) is expressed, a Notch signal is provided,  
which results in the development of T/NK cell (CD25+Thy1.2+CD49b+) precursors. Both 
wild  type  and  Justy pre-pro-B  cell  cultures  gave  rise  to  similar  number  of  cells. 
Furthermore,  the  number  of  CD25+Thy1.2+CD49b+ T/NK  cells  was  also  similar, 
suggesting that the survival and proliferation of Justy pre-pro-B cells are not entirely 
defective. Furthermore, it provides evidence, that pre-pro-B cells are capable of giving 
rise to lineages other than B cells. In either early pro-B cell cultures, however, the cells  
did not expand which corresponds with the commitment of early-pro-B cells into the B 
lineage. 
Gon4l paralog is widely expressed in various tissues
Interestingly, the  Gon4l  locus has undergone duplication in mice at some point 
after speciation from other rodents, resulting in a paralog that is immediately upstream 
of Gon4l and which lacks exons 4-11 and 26-33 from Gon4l but contains all other exons. 
VISTA Browser (Berkeley National Laboratory) analysis showed that Gon4l homologues 
exist in all mammals examined as well as in frog (Xenopus tropicalis) and zebrafish. A 
Gon4l gene homologue was not found in the chicken genome in its present form, but a 
cDNA (XM_422861) with  homology to  Gon4l has been isolated from these species. 
Results from the VISTA website indicate that a Gon4l paralog homologue does not exist 
in other rodent species. One explanation for this is that  Gon4l paralog arose relatively 
recently  in  mouse  following  its  divergence  from other  rodent  species.  The  putative 
protein encoded by this paralog would lack the C-terminal PAH and SANT domains as 
well  as the putative nuclear localization signal  (NLS), suggesting that this protein,  if 
expressed, would be excluded from the nucleus. 
While it is clear that Gon4l paralog was generated via partial duplication of Gon4l, 
it  is  not  known  whether  Gon4l  paralog expresses  an  mRNA  or  protein  or  is  a 
pseudogene.  Thus,  we ought  to  determine the  expression  pattern  of  Gon4l  paralog 
mRNA, if present, in different tissues. We developed a  Gon4l paralog specific Q RT-
PCR method. The difficulty of differentiating  Gon4l paralog from Justy is coming from 
the almost 100% similarity among exons shared by both mRNA. We took advantage of  
single nucleotide differences spanning across exon 22 and designed primers that are 
specific for Gon4l paralog but do not amplify Gon4l. We ordered HPLC purified oligos to 
increase specificity and using plasmids encoding region from exon 22 of either  Gon4l 
paralog or  Gon4l DNA. We developed an assay where the amplification is specific for 
Gon4l paralog but not for  Gon4l. The Q RT-PCR analysis indicated that this gene is 
widely expressed in different tissues. Based on our prediction that it lacks the NLS it  
cannot substitute for Gon4l, at least in the nucleus. Interestingly, we have found that the 
mRNA level decreases during transition from pre-pro-B to early pro-B cells in both wild-
type and  Justy cells. This suggests that  Gon4l paralog may have a role during B cell 
development; however, whether its role in the cytoplasm is similar to Gon4l will need to 
be further defined.
Socs7 negatively regulates IL-Rα expression
IL-7 and TSLP are both key cytokines during B cell development. IL-7Rα is the 
common receptor for both IL-7 and Tslp. As I observed decreased IL-7Rα expression in 
Justy  early  pro-B  cells,  I  wanted  to  learn  more  about  the  underlying  mechanism 
regulating  IL-7Rα expression.  It  has  been  reported  that  Tslp  signaling  involves  the 
activation of Stat5 in a pre-B cell line. Furthermore, Stat5 has been shown to be a key 
player entraining B cell development downstream of the IL-7R pathway. As Socs7 has 
been  shown  to  interact  with  Stat5  in  vitro  I  hypothesised  that  Socs7  might  be  a 
suppressor of Tslp/IL-7 signaling. 
Socs7 deficient mice exhibit a severe skin disease that resembles human atopy. 
These mice showed increased mast cell  degranulation in the affected skin.  As mast 
cells both express and respond to Tslp, I decided to analyze bone marrow derived mast 
cells  (BMMCs)  from both  wild-type  and  Socs7-/-  mice.  BMMCs were  stimulated  by 
FcεRI aggregation. mRNA levels of Tslp and its heterodimeric receptor consisting of IL-
7rα and Tslpr  were  determined.  There  was no change in  Tslpr  mRNA levels  upon 
stimulation of either Socs7-/-  or control mast cells. IL-7rα mRNA levels, however, were 
increased in a time-dependent manner in both Socs7-/- and wild type mast cells. There 
was a greater increase in IL-7rα mRNA expression in the absence of Socs7 (p=0.04 
after 2 hours of treatment).  Although there was almost no detectable Tslp mRNA in 
control  BMMCs  after  30  minutes  stimulation,  Tslp  mRNA  was  detected  in  BMMCs 
obtained  from  Socs7-/- mice  as  early  as  30  minutes  and  increased  with  prolonged 
stimulation.  After  2  and  4  hours  of  stimulation,  Socs7 -/- mast  cells  produced 
approximately 4.5 fold more Tslp transcript than control cells. In control BMMCs, the 
level of Socs7 transcript was increased upon stimulation (0 vs 2h: p=0.003; 0 vs 4h: 
p=0.002). 
Other  Socs  proteins  have  been  shown  to  target  proteins  for  proteasomal 
degradation, thus I determined whether Socs7 interact with the Elongin B/C complex. 
Xpress epitope tagged full-length and ∆Sox Box (∆SB) Socs7 cDNAs were transfected 
into HEK293 cells together with HA epitope tagged Elongin C. Lysates from these cells  
were subjected to immunoprecipitation and blotted with an antibody recognizing Elongin 
C  (a-HA).  While  full-length  Socs7  bound  to,  the  ∆SB mutant  failed  to  interact  with 
Elongin  C.  These  results  demonstrate  that  Socs7  can  interact  with  Elongin  C  and 
suggest that Socs7 targets IL-7Rα for proteosomal degradation.
SUMMARY
B  cell  development  occurs  through  several  stages  and  regulated  by  the 
combinatorial  activity  of  growth factors and their  receptors as well  as transcriptional 
regulators. In this work I have presented the work I performed to understand more about 
the complex mechanism underlying B cell development. I have analyzed a mouse model 
named  Justy  (for  just  T  cells)  generated  by  ENU  induced  mutation.  The  causal 
recessive mutation results in a profound, cell-intrinsic block in B lymphopoiesis and in 
the almost complete absence of B220+CD19+ pre-B cells in the bone marrow, as well  
as mature B cells in the periphery, but has no apparent effect on the development of 
other hematopoietic cell lineages. The Justy mutation was mapped to an intron within a 
poorly  characterized  gene  named  Gon4l.  Molecular  analysis  demonstrated  that  the 
mutation disrupts splicing of Gon4l RNA, resulting in the absence of wild-type Gon4l 
mRNA expression in Justy pre-pro-B and early pro-B cells. I have also demonstrated 
that the Gon4l protein localizes to the nucleus and predicted to form domains found in 
other  proteins  that  function  as  transcriptional  co-repressors.  QRT-PCR experiments, 
consistent with the gene expression profiling on pre-pro-B and early pro-B cells from 
Justy mice, demonstrated that Gon4l is important for reprogramming gene expression 
during lineage commitment phase of B lymphopoiesis. Further analyses depicting the 
role of Gon4l in the potential of pre-pro-B and early pro-B cell to develop into alternative 
lineages suggest that Justy cells are able to differentiate into other then B cells, thus the  
mutation results in a defect specific for B cell development. Furthermore, I suggested a 
mechanism for the regulation of IL-7/TSLP signaling. These cytokines play important 
roles during B cell development and learning more about the mechanisms that regulate 
them will  deepen our  understanding about  hematopoiesis.  I  have shown that  Socs7 
negatively  regulates  IL-7Rα  expression  and  TSLP  production  by  mast  cells  and 
proposed that Socs7 targets IL-7Rα for proteosomal degradation.
All together, my analyses provide new insights into the regulation of B lineage 
commitment.
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